Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas

Abstract

Tumor size did not predict malignancy or recurrence of PPGLs. PPGL patients with characteristic pathologic findings and PASS ≥4 or germline mutations require close follow-up.